Rexall Feminine Maximum Strength Anti-itch
NDC Package 55910-415-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Rexall Feminine Maximum Strength Anti-itch is adults and children 12 years and olderapply a fingertip amount (approximately 1-inch strip) to Tthe affected area not more than 3 to 4 times dailychildren under 12 yearsconsult a doctor. Marketed by Dolgencorp, Inc., this product is identified by NDC 55910-415 and is authorized under FDA application part346.

Identification & Billing

NDC Package Code
55910-415-03
Package Description
28 g in 1 TUBE
Product Code
55910-415
11-Digit Billing Format
55910041503
RxNorm Crosswalk
  • RxCUI: 637518 - benzocaine 20 % / resorcinol 3 % Vaginal Cream
  • RxCUI: 637518 - benzocaine 200 MG/ML / resorcinol 30 MG/ML Vaginal Cream

Clinical Specifications

Proprietary Name
Rexall Feminine Maximum Strength Anti-itch
Dosage Form
-
Usage Information
Adults and children 12 years and olderapply a fingertip amount (approximately 1-inch strip) to Tthe affected area not more than 3 to 4 times dailychildren under 12 yearsconsult a doctor

Regulatory & Marketing

Labeler Name
Dolgencorp, Inc.
FDA Application #
part346
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
09-27-2016
Listing Expiration
12-31-2019
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55910-415-03 identifies a specific commercial package of 28 g in 1 tube of Rexall Feminine Maximum Strength Anti-itch, labeled by Dolgencorp, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Dolgencorp, Inc. on September 27, 2016. The current certification is valid through December 31, 2019.

How is this Dolgencorp, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55910041503. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
55910-415-03
11-Digit CMS (5-4-2)
55910-0415-03

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.